Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 22 Breast Neoplasms 21 Neoplasms 10 Brain Neoplasms 10 Glioma 8 Head and Neck Neoplasms 7 Lymphoma 6 Colonic Neoplasms 6 Urinary Bladder Neoplasms 5 Rectal Neoplasms 5 Pancreatic Neoplasms 5 Lymphoma, Non-Hodgkin 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Glioblastoma 4 Carcinoma, Hepatocellular 4 Astrocytoma 4 Squamous Cell Carcinoma of Head and Neck 3 Spinal Cord Neoplasms 3 Lung Neoplasms 3 Stomach Neoplasms 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Oligodendroglioma 2 Neurofibromatosis 1 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Meningioma 2 Lymphoma, B-Cell 2 Liver Neoplasms 2

Interventions

pembrolizumab 1 gadobutrol 1 Standard of Care 1 Radiotherapy 1 Radiation 1 Proton Therapy 1 Practice Guidelines as Topic 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Limonene 1 Erlotinib Hydrochloride 1 Docetaxel 1 Citric Acid 1 Cisplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Parotid Neoplasms × Magnetic Resonance Imaging × Clear all

NCT02294838 2016-11-28

SPIT

British Columbia Cancer Agency

Phase NA Unknown

Parotid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡